The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) P/B ratio
As of 5 November 2026, The Chemours Company (CC) trades at a P/B ratio of 12.4×. Over the past ten years it has ranged from 0.0× (September 2026) to 66.6× (March 2017); the current reading is higher than 87% of that period. That is above the Specialty Chemicals industry median of 1.9× and above the Basic Materials sector median of 1.7×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 7.1× | 59.77% |
| FY2024 | 4.4× | (31.03%) |
| FY2023 | 6.4× | 49.02% |
| FY2022 | 4.3× | (16.00%) |
| FY2021 | 5.1× | 2.13% |
| FY2020 | 5.0× | 16.76% |
| FY2019 | 4.3× | (12.38%) |
| FY2018 | 4.9× | (55.72%) |
| FY2017 | 11.1× | (70.16%) |
| FY2016 | 37.1× | 396.59% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 13.2× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 15.4× | 117.90% |
| Dec 2025 | 7.1× | (11.09%) |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| STDN Standard Nuclear Inc compare | n/m |
| FUL H. B. Fuller Company compare | 1.3× |
| SCL Stepan Company compare | 1.3× |
| IOSP Innospec Inc. compare | 1.4× |
| KWR Quaker Houghton compare | 1.9× |
| WDFC WD-40 Company compare | 11.2× |
| CC The Chemours Company | 12.4× |
| NGVT Ingevity Corporation compare | 47.9× |
| MTX Minerals Technologies Inc. compare | 59.1× |
| Specialty Chemicals industry median | 1.9× |
| Basic Materials sector median | 1.7× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement